1 terminated. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
Follow Tami D. John: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP Busulfan, Campath 1H, Cyclophosphamide and MESNA - Sickle Cell Disease, Hemoglobin SC | Not applicable | Terminated | Tami D. John | 8 | 2005-07-01 | 2020-07-31 |
Anemia (1) · Anemia, Sickle Cell (1) · Hemoglobin SC Disease (1)
Alemtuzumab (1) · Busulfan (1) · Cyclophosphamide (1) · Mesna (1)
United States (1)
Tami John, MD (1)